Serum thiols as a biomarker of disease activity in lupus nephritis.

Lupus Nephritis (LN) develops in more than half of the Systemic Lupus Erythematous (SLE) patients. However, lack of reliable, specific biomarkers for LN hampers clinical management of patients and impedes development of new therapeutics. The goal of this study was to investigate whether oxidative st...

Full description

Bibliographic Details
Main Authors: Pritesh Lalwani, Giselle Katiane Bonfim Bacelar de Souza, Domingos Savio Nunes de Lima, Luiz Fernando Souza Passos, Antonio Luiz Boechat, Emerson Silva Lima
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0119947